e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Respiratory disease within hospital-based populations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Current maintenance treatment of chronic obstructive pulmonary disease in China
C. Wang, J. Han, K. Huang, J. Zheng, L. Dai, INTACT Study Investigators (Beijing, Guangzhou, China)
Source:
International Congress 2014 – Respiratory disease within hospital-based populations
Session:
Respiratory disease within hospital-based populations
Session type:
Thematic Poster Session
Number:
4108
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Wang, J. Han, K. Huang, J. Zheng, L. Dai, INTACT Study Investigators (Beijing, Guangzhou, China). Current maintenance treatment of chronic obstructive pulmonary disease in China. Eur Respir J 2014; 44: Suppl. 58, 4108
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The economical effect of inhaler in patients with early chronic obstructive pulmonary disease
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 903-908
Year: 2001
The effectiveness of anti-inflammatory therapy for chronic obstructive pulmonary disease complicated by ischemic heart disease (new medication - new opportunities)
Source: International Congress 2014 – Comorbidities
Year: 2014
Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Pulmonary rehabilitation for acute exacerbations of chronic obstructive pulmonary disease (COPD): A systematic review
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Modern treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 60S-66S
Year: 2001
LATE-BREAKING ABSTRACT: A home-centered disease management program in severe chronic obstructive pulmonary disease (Results of the COPD patient Management European Trial-COMET)
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010
Emerging anti-inflammatory strategies for COPD},
Source: Eur Respir J 2012; 40: 724-741
Year: 2012
Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014
Socioeconomic burden of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463
Year: 2006
Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Medical and demographic loss of population due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Palliation of patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016
Predictors of exacerbation frequency in chronic obstructive pulmonary disease
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Diagnosis of chronic obstructive pulmonary disease (COPD) - are guidelines being implemented in primary care?
Source: Eur Respir J 2001; 18: Suppl. 33, 347s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept